Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RITUXIMAB Cause Blood alkaline phosphatase increased? 293 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 293 reports of Blood alkaline phosphatase increased have been filed in association with RITUXIMAB (Rituxan). This represents 0.2% of all adverse event reports for RITUXIMAB.

293
Reports of Blood alkaline phosphatase increased with RITUXIMAB
0.2%
of all RITUXIMAB reports
22
Deaths
101
Hospitalizations

How Dangerous Is Blood alkaline phosphatase increased From RITUXIMAB?

Of the 293 reports, 22 (7.5%) resulted in death, 101 (34.5%) required hospitalization, and 40 (13.7%) were considered life-threatening.

Is Blood alkaline phosphatase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 293 reports have been filed with the FAERS database.

What Other Side Effects Does RITUXIMAB Cause?

Off label use (39,751) Drug ineffective (32,186) Rheumatoid arthritis (19,850) Pain (16,675) Fatigue (15,602) Arthralgia (12,529) Rash (12,102) Drug intolerance (11,876) Infusion related reaction (11,871) Joint swelling (11,170)

What Other Drugs Cause Blood alkaline phosphatase increased?

TERIPARATIDE (372) FINGOLIMOD (332) ACETAMINOPHEN (331) NIVOLUMAB (301) RIBOCICLIB (289) ASFOTASE ALFA (283) METHOTREXATE (272) LETROZOLE (266) ATORVASTATIN (262) OBETICHOLIC ACID (251)

Which RITUXIMAB Alternatives Have Lower Blood alkaline phosphatase increased Risk?

RITUXIMAB vs RITUXIMAB-ABBS RITUXIMAB vs RITUXIMAB-ARRX RITUXIMAB vs RITUXIMAB-PVVR RITUXIMAB vs RIVAROXABAN RITUXIMAB vs RIVASTIGMINE

Related Pages

RITUXIMAB Full Profile All Blood alkaline phosphatase increased Reports All Drugs Causing Blood alkaline phosphatase increased RITUXIMAB Demographics